ELEVATED LP(A)

Clinical trials for ELEVATED LP(A) explained in plain language.

Never miss a new study

Get alerted when new ELEVATED LP(A) trials appear

Sign up with your email to follow new studies for ELEVATED LP(A), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New pill aims to cut heart attacks in people with 'Hidden' cholesterol risk

Disease control Recruiting now

This Phase 3 trial tests an oral drug called muvalaplin in over 10,000 adults with high levels of lipoprotein(a), a genetic risk factor for heart disease and stroke. Participants either have had a prior cardiovascular event or are at high risk for a first one. The study measures …

Matched conditions: ELEVATED LP(A)

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

ELEVATED LP(A)

Get alerted when new ELEVATED LP(A) trials appear

New pill aims to cut heart attacks in people with 'Hidden' cholesterol risk